Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Christopher Kingswood

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
American Journal of Medical Genetics. Part C, Seminars in Medical Genetics|October 12, 2018
Renal manifestation of tuberous sclerosis complexJohn J Bissler, J Christopher Kingswood
Critical Reviews in Oncogenesis|February 3, 2023
Progress in Tuberous Sclerosis Complex Renal DiseaseJohn J Bissler, Dinah Batchelor, J Christopher Kingswood
Nature Reviews. Disease Primers|May 27, 2016
Tuberous sclerosis complexElizabeth P Henske, Sergiusz Jóźwiak, J Christopher Kingswood, et al.
Plos One|October 13, 2017
Pooled analysis of menstrual irregularities from three major clinical studies evaluating everolimus for the treatment of tuberous sclerosis complexSteven Sparagana, David N Franz, Darcy A Krueger, et al.
Pediatric Nephrology (Berlin, Germany)|October 11, 2017
The effect of everolimus on renal angiomyolipoma in pediatric patients with tuberous sclerosis being treated for subependymal giant cell astrocytomaJohn J Bissler, David N Franz, Michael D Frost, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|July 28, 2018
Effect of everolimus on renal function in patients with tuberous sclerosis complex: evidence from EXIST-1 and EXIST-2John J Bissler, Klemens Budde, Matthias Sauter, et al.
Orphanet Journal of Rare Diseases|May 2, 2019
A step-wise approach for establishing a multidisciplinary team for the management of tuberous sclerosis complex: a Delphi consensus reportStéphane Auvin, John J Bissler, Vincent Cottin, et al.
Drugs|March 2, 2016
The Role of mTOR Inhibitors in the Treatment of Patients with Tuberous Sclerosis Complex: Evidence-based and Expert OpinionsPaolo Curatolo, Marit Bjørnvold, Patricia E Dill, et al.
Lancet (London, England)|January 15, 2013
Everolimus for angiomyolipoma associated with tuberous sclerosis complex or sporadic lymphangioleiomyomatosis (EXIST-2): a multicentre, randomised, double-blind, placebo-controlled trialJohn J Bissler, J Christopher Kingswood, Elżbieta Radzikowska, et al.
Frontiers in Psychiatry|March 17, 2022
Empowering Families Through Technology: A Mobile-Health Project to Reduce the TAND Identification and Treatment Gap (TANDem)Tosca-Marie Heunis, Stacey Bissell, Anna W Byars, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
American Journal of Medical Genetics. Part C, Seminars in Medical Genetics|October 12, 2018
Renal manifestation of tuberous sclerosis complexJohn J Bissler, J Christopher Kingswood
Critical Reviews in Oncogenesis|February 3, 2023
Progress in Tuberous Sclerosis Complex Renal DiseaseJohn J Bissler, Dinah Batchelor, J Christopher Kingswood
Nature Reviews. Disease Primers|May 27, 2016
Tuberous sclerosis complexElizabeth P Henske, Sergiusz Jóźwiak, J Christopher Kingswood, et al.
Plos One|October 13, 2017
Pooled analysis of menstrual irregularities from three major clinical studies evaluating everolimus for the treatment of tuberous sclerosis complexSteven Sparagana, David N Franz, Darcy A Krueger, et al.
Pediatric Nephrology (Berlin, Germany)|October 11, 2017
The effect of everolimus on renal angiomyolipoma in pediatric patients with tuberous sclerosis being treated for subependymal giant cell astrocytomaJohn J Bissler, David N Franz, Michael D Frost, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|July 28, 2018
Effect of everolimus on renal function in patients with tuberous sclerosis complex: evidence from EXIST-1 and EXIST-2John J Bissler, Klemens Budde, Matthias Sauter, et al.
Orphanet Journal of Rare Diseases|May 2, 2019
A step-wise approach for establishing a multidisciplinary team for the management of tuberous sclerosis complex: a Delphi consensus reportStéphane Auvin, John J Bissler, Vincent Cottin, et al.
Drugs|March 2, 2016
The Role of mTOR Inhibitors in the Treatment of Patients with Tuberous Sclerosis Complex: Evidence-based and Expert OpinionsPaolo Curatolo, Marit Bjørnvold, Patricia E Dill, et al.
Lancet (London, England)|January 15, 2013
Everolimus for angiomyolipoma associated with tuberous sclerosis complex or sporadic lymphangioleiomyomatosis (EXIST-2): a multicentre, randomised, double-blind, placebo-controlled trialJohn J Bissler, J Christopher Kingswood, Elżbieta Radzikowska, et al.
Frontiers in Psychiatry|March 17, 2022
Empowering Families Through Technology: A Mobile-Health Project to Reduce the TAND Identification and Treatment Gap (TANDem)Tosca-Marie Heunis, Stacey Bissell, Anna W Byars, et al.
Pageof 2